Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enhancing Exposure Therapy for Spider Phobia With the Use of Threat-Relevant and Threat-Irrelevant Opposite Actions

NCT02905279 is registered in ClinicalTrials.gov with University of Texas at Austin as lead sponsor.

NCT NCT02905279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02905279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enhancing Exposure Therapy for Spider Phobia With the Use of Threat-Relevant and Threat-Irrelevant Opposite Actions
Lead sponsor
University of Texas at Austin
Phase
Not applicable
Overall status
Terminated
Start date
June 1, 2016
Completion date
December 12, 2017
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

specific phobia